|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,470.00 KRW | +4.59% |
|
+18.91% | -19.79% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/25/12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.59% | +18.91% | +20.88% | -26.38% | -19.79% | -32.22% | - | - | - | 8.78Cr | |
| -0.07% | +17.77% | +17.95% | +59.89% | +38.98% | +102.75% | +496.93% | +201.32% | +2,955.66% | 4.64TCr | |
| +0.28% | +3.66% | +15.12% | +24.93% | +27.02% | +19.05% | +48.90% | +5.64% | +127.38% | 2.59TCr | |
| +0.67% | +2.47% | +4.87% | +18.27% | -0.93% | -19.02% | -34.52% | -45.10% | +2.80% | 776.42Cr | |
| +6.36% | +14.56% | +16.65% | +36.90% | +7.25% | +23.43% | +139.82% | +127.28% | +1,128.33% | 569.19Cr | |
| +1.16% | +2.56% | +15.99% | +18.44% | +31.80% | +22.50% | +63.98% | +0.48% | +328.81% | 339.07Cr | |
| +1.73% | +14.05% | +17.91% | +95.39% | -40.49% | -29.98% | +1,354.79% | -80.84% | - | 229.87Cr | |
| -0.18% | +4.70% | +17.54% | +91.51% | +41.03% | +184.97% | +17.58% | -60.80% | +106.02% | 212.88Cr | |
| +6.83% | +11.49% | +35.21% | +10.02% | +9.13% | +2.48% | -53.01% | -77.24% | - | 198.86Cr | |
| +4.04% | +15.84% | +15.27% | +0.24% | +33.38% | +33.80% | -8.80% | -39.46% | -32.72% | 184Cr | |
| +3.07% | +3.59% | +1.07% | +8.89% | +31.25% | +32.08% | +185.31% | - | - | 146.08Cr | |
| +1.76% | +3.66% | +5.65% | +13.26% | +4.55% | +9.71% | +38.29% | +22.31% | -30.39% | 121.19Cr | |
| +1.09% | +5.34% | +2.22% | +23.21% | +9.52% | +6.15% | -24.18% | -62.70% | -86.09% | 102.25Cr | |
| +2.99% | +7.33% | +16.30% | +28.05% | +39.37% | +39.86% | +226.21% | +38.75% | +237.15% | 100.94Cr | |
| +2.22% | +19.42% | +19.51% | +0.46% | +14.38% | -5.53% | -34.86% | -75.73% | - | 89Cr | |
| -0.42% | -0.28% | -2.32% | -6.54% | -7.38% | +2.73% | +21.81% | -10.51% | +46.22% | 85Cr | |
| -2.29% | +1.43% | +2.40% | -6.17% | -16.14% | -22.83% | -29.47% | -59.96% | +26.04% | 57Cr | |
| +5.39% | +13.68% | +18.55% | -8.62% | +7.78% | -6.91% | -37.77% | - | - | 56Cr | |
| +3.83% | +26.12% | +4.10% | -7.84% | -5.82% | +27.50% | +21.06% | - | - | 55Cr | |
| -0.99% | +8.63% | -6.91% | +20.92% | -27.18% | -7.18% | -41.17% | -80.35% | - | 53Cr | |
| Average | +2.01% | +8.81% | +11.90% | +19.74% | +8.89% | +19.17% | +123.73% | -12.31% | +400.77% | 530.83Cr | |
| Weighted average by Cap. | +0.38% | +12.10% | +15.48% | +40.94% | +26.45% | +54.74% | +269.35% | +88.65% | +1,517.58% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
